by Robert White | Apr 30, 2019 | Bulletin
In a few weeks, a mysterious new biotech company will launch an anti-aging pill on the US market. Very little is known about this pill. The promotional material claims it will “modulate the pathways associated with aging”. And based on studies so far, it will add...
by Robert White | Apr 26, 2019 | Bulletin
What’s the big news this week for UK investors? It’s not that Sainsbury’s bid for Asda has been blocked by the Competition and Markets Authority. At least, on the face of it that’s not too important – not yet. Although perhaps in a few years’ time we’ll look back on...
by Robert White | Apr 23, 2019 | Bulletin
An experiment: hold out your right arm and then slowly flex your wrist. Which comes first – the thought to flex your wrist, or the action itself? In the 1980s, an experiment by the neurologist Benjamin Libet raised some disturbing questions about the extent to which...
by Robert White | Apr 18, 2019 | Bulletin
You’ve got to feel for those poor investors who hailed a ride on the Lyft bandwagon… … just as the price peaked on the day of its IPO. Say they got in at the top, at $88.30, as new issue euphoria reached maximum. They’d have been pleased to be in on the hottest...
by Robert White | Apr 16, 2019 | Bulletin
The machine itself doesn’t look very impressive. In fact, it looks more like a home experiment…something you might use to distil your own gin or vodka. The are a few working parts: some glass bottles…some chemicals…a few sequencing devices. In total it cost...
Recent Comments